Changes may be needed to improve the usefulness of remission definitions
T2T in real-life helps people get to remission
Unclear benefit of Zostavax in people starting on tofacitinib
Arthritis induced by cancer therapy may persist after stopping treatment
SSR可以给几人用
ARD/RMD Open Social media
LSM Social media
Categories
ANCA-associated vasculitis
Ankylosing spondylitis
Antiphospholipid syndrome
Autoimmune disease
Biologic drugs
Breast cancer
Cardiovascular disease
Cervical cancer
Chronic pain
Comorbidities
Corticosteroids
Diet and nutrition
Disease Activity Scoring
Drug treatment
EULAR recommendations
Giant cell arteritis
Gout
Imaging techniques
Inflammatory arthritis
Juvenile idiopathic arthritis
Lupus nephritis
Metabolic syndrome
NSAIDs
Osteoarthritis
Osteoporosis
Paediatrics
Patient-physician relationship
SSR可以给几人用
SSR可以给几人用
Psoriatic arthritis
SSR可以给几人用
Rheumatoid arthritis
Septic arthritis
Sjögren's syndome
Smoking
Spine
Spondyloarthritis
Steroids
Systemic lupus erythematosus
SSR可以给几人用
SSR可以给几人用
Topic index
SSR可以给几人用
Patient Summaries are intended to educate and inform those readers who may not be medically trained by outlining the key points of scientific articles written by medical professionals. Readers should be aware that professionals in the field may have different opinions. Any views expressed are solely those of the author(s) of the original article and are not endorsed or vetted by BMJ Publishing Group Limited (BMJ). Information is provided on an “as is” basis without any representations, conditions or warranties that it is accurate and up to date. The content is not intended to function as a substitute for a healthcare practitioner’s judgement and readers are advised to consult their own medical professional for all aspects of their health care. Readers agree not to use the content as the basis for their own medical treatment or for the medical treatment of others. To the fullest extent permitted by law, BMJ disclaims all liability and responsibility arising from any reliance placed on this content.